155 related articles for article (PubMed ID: 36669141)
1. Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.
Mo DC; Huang JF; Luo PH
J Clin Oncol; 2023 Mar; 41(9):1790. PubMed ID: 36669141
[No Abstract] [Full Text] [Related]
2. Head and neck cancer: metronomic chemotherapy.
De Felice F; Musio D; Tombolini V
BMC Cancer; 2015 Oct; 15():677. PubMed ID: 26459302
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
Patil VM; Noronha V; Menon N; Rai R; Bhattacharjee A; Singh A; Nawale K; Jogdhankar S; Tambe R; Dhumal S; Sawant R; Alone M; Karla D; Peelay Z; Pathak S; Balaji A; Kumar S; Purandare N; Agarwal A; Puranik A; Mahajan A; Janu A; Kumar Singh G; Mittal N; Yadav S; Banavali S; Prabhash K
J Clin Oncol; 2023 Jan; 41(2):222-232. PubMed ID: 36265101
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Head and Neck Cancer Patients Treated with Palliative Oral Metronomic Chemotherapy at a Tertiary Cancer Center in Kerala, India.
Nv V; Muttath G; Jones J; Shringarpure K; Duraisamy K; Deenathayalan VP; Rathi P
Gulf J Oncolog; 2020 May; 1(33):68-74. PubMed ID: 32476653
[TBL] [Abstract][Full Text] [Related]
5. Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.
Patil VM; Noronha V; Joshi A; Agarwala V; Muddu V; Ramaswamy A; Chandrasekharan A; Dhumal S; Juvekar S; Arya A; Bhattacharjee A; Prabhash K
Indian J Cancer; 2017; 54(1):20-24. PubMed ID: 29199655
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.
Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Bhosale B; Arya S; Juvekar S; Banavali S; D'Cruz A; Bhattacharjee A; Prabhash K
Oral Oncol; 2015 Mar; 51(3):279-86. PubMed ID: 25578869
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of head and neck cancer.
Kies MS; Levitan N; Hong WK
Otolaryngol Clin North Am; 1985 Aug; 18(3):533-41. PubMed ID: 4047673
[TBL] [Abstract][Full Text] [Related]
8. Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia).
Harsh KK; Maharia SR; Nirban RK; Khatri P; Beniwal S; Kumar HS; Jakhar SL
J Cancer Res Ther; 2020; 16(3):559-564. PubMed ID: 32719267
[TBL] [Abstract][Full Text] [Related]
9. Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.
Patil VM; Noronha V; Joshi A; Abhyankar A; Menon N; Dhumal S; Prabhash K
Oral Oncol; 2020 Jun; 105():104673. PubMed ID: 32272385
[TBL] [Abstract][Full Text] [Related]
10. Metronomic chemotherapy in head and neck cancer.
De Felice F; Benevento I; Musella A; Musio D; Tombolini V
Cancer Lett; 2017 Aug; 400():219-222. PubMed ID: 27832971
[TBL] [Abstract][Full Text] [Related]
11. Current status of systemic therapy in head and neck cancer.
Mittal A; Sharma A
J Chemother; 2022 Feb; 34(1):9-24. PubMed ID: 34308772
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of neoadjuvant chemotherapy with cisplatin plus 5-fluorouracil, with or without leucovorin, in locally advanced head and neck cancer.
Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Muñoz A; Pardal JL
Ann Oncol; 1997 Jul; 8(7):713-4. PubMed ID: 9296230
[No Abstract] [Full Text] [Related]
13. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for recurrent/metastatic head and neck cancers.
Karabajakian A; Toussaint P; Neidhardt EM; Paulus V; Saintigny P; Fayette J
Anticancer Drugs; 2017 Apr; 28(4):357-361. PubMed ID: 28166090
[TBL] [Abstract][Full Text] [Related]
15. Oral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers.
Patil V; Noronha V; Krishna V; Joshi A; Prabhash K
Clin Oncol (R Coll Radiol); 2013 Jun; 25(6):388. PubMed ID: 23434353
[No Abstract] [Full Text] [Related]
16. RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
Patil V; Noronha V; Joshi A; Menon N; Mathrudev V; Bhattacharjee A; Chandrasekharan A; Vallathol D; Dsouza H; Srinivas S; Mandal T; Chaturvedi P; Chaukar D; Pai P; Nair S; Thiagrajan S; Laskar S; Nawale K; Babanrao Dhumal S; Tambe R; Banavali S; Prabhash K
Oral Oncol; 2022 May; 128():105816. PubMed ID: 35367787
[TBL] [Abstract][Full Text] [Related]
17. Response to immunotherapy rechallenge after interval chemotherapy in a patient with head and neck cancer.
Cabezas-Camarero S; Cabrera-Martín MN; Pérez-Segura P
Anticancer Drugs; 2019 Feb; 30(2):149-152. PubMed ID: 30339560
[TBL] [Abstract][Full Text] [Related]
18. Use of chemotherapy to cure head and neck cancer.
Taylor SG
J Infus Chemother; 1995; 5(2):44-5. PubMed ID: 8521233
[No Abstract] [Full Text] [Related]
19. What is the optimal regimen of cisplatin plus 5-FU for head and neck cancer?
Chen MC
Oncology (Williston Park); 1990 Feb; 4(2):19. PubMed ID: 2143665
[No Abstract] [Full Text] [Related]
20. Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Vermorken JB; Mesia R; Rivera F; Remenar E; Kawecki A; Rottey S; Erfan J; Zabolotnyy D; Kienzer HR; Cupissol D; Peyrade F; Benasso M; Vynnychenko I; De Raucourt D; Bokemeyer C; Schueler A; Amellal N; Hitt R
N Engl J Med; 2008 Sep; 359(11):1116-27. PubMed ID: 18784101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
